EMDEX

FDA recalls Valsartan due to contamination with a potential cancer-causing impurity

The U.S. Food and Drug Administration is alerting health care professionals and patients of a voluntary recall of several drug products containing the active ingredient valsartan, used to treat high blood pressure and heart failure. This recall is due to an impurity, N-nitrosodimethylamine (NDMA), which was found in the recalled products. However, not all products containing valsartan are being recalled. NDMA is classified as a probable human carcinogen (a substance that could cause cancer) based on results from laboratory tests.

Find the brands of Valsartan in your EMDEX app. Available for Download on Google Play

READ MORE

Chat with us
EMDEX Inquiries? Chat with us
Chat with an EMDEX representative